Presidio Management Group Viii L L C - Net Worth and Insider Trading
Presidio Management Group Viii L L C Net Worth
The estimated net worth of Presidio Management Group Viii L L C is at least $92 Million dollars as of 2024-11-12. Presidio Management Group Viii L L C is the 10% Owner of AtriCure Inc and owns about 1,895,128 shares of AtriCure Inc (ATRC) stock worth over $72 Million. Presidio Management Group Viii L L C is the 10% Owner of Guidewire Software Inc and owns about 100,372 shares of Guidewire Software Inc (GWRE) stock worth over $20 Million. Presidio Management Group Viii L L C is also the 10% Owner of OncoMed Pharmaceuticals Inc and owns about 33,067 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $29,430. Besides these, Presidio Management Group Viii L L C also holds MaxLinear Inc (MXL) . Details can be seen in Presidio Management Group Viii L L C's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Presidio Management Group Viii L L C has not made any transactions after 2014-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Presidio Management Group Viii L L C
Presidio Management Group Viii L L C Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Presidio Management Group Viii L L C owns 6 companies in total, including OncoMed Pharmaceuticals Inc (OMED) , Guidewire Software Inc (GWRE) , and MaxLinear Inc (MXL) among others .
Insider Ownership Summary of Presidio Management Group Viii L L C
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OMED | OncoMed Pharmaceuticals Inc | 2014-08-08 | 10 percent owner |
| GWRE | Guidewire Software Inc | 2012-09-18 | 10 percent owner |
| MXL | MaxLinear Inc | 2012-05-30 | 10 percent owner |
 | | 2012-06-07 | 10 percent owner |
| | 2011-11-15 | 10 percent owner |
| | 2005-07-26 | 10 percent owner |
Presidio Management Group Viii L L C Latest Holdings Summary
Presidio Management Group Viii L L C currently owns a total of 4 stocks. Among these stocks, Presidio Management Group Viii L L C owns 1,895,128 shares of AtriCure Inc (ATRC) as of June 7, 2012, with a value of $72 Million and a weighting of 78.65%. Presidio Management Group Viii L L C owns 100,372 shares of Guidewire Software Inc (GWRE) as of September 18, 2012, with a value of $20 Million and a weighting of 21.32%. Presidio Management Group Viii L L C also owns 33,067 shares of OncoMed Pharmaceuticals Inc (OMED) as of June 10, 2014, with a value of $29,430 and a weighting of 0.03%. The other 1 stocks MaxLinear Inc (MXL) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Presidio Management Group Viii L L C
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRC | AtriCure Inc | 2012-06-07 | 1,895,128 | 38.23 | 72,450,743 |
| GWRE | Guidewire Software Inc | 2012-09-18 | 100,372 | 195.62 | 19,634,771 |
| OMED | OncoMed Pharmaceuticals Inc | 2014-06-10 | 33,067 | 0.89 | 29,430 |
| MXL | MaxLinear Inc | 2012-05-30 | 0 | 16.01 | 0 |
Holding Weightings of Presidio Management Group Viii L L C
Presidio Management Group Viii L L C Form 4 Trading Tracker
According to the SEC Form 4 filings, Presidio Management Group Viii L L C has made a total of 0 transactions in AtriCure Inc (ATRC) over the past 5 years. The most-recent trade in AtriCure Inc is the sale of 5,038 shares on June 7, 2012, which brought Presidio Management Group Viii L L C around $47,559.
According to the SEC Form 4 filings, Presidio Management Group Viii L L C has made a total of 0 transactions in Guidewire Software Inc (GWRE) over the past 5 years. The most-recent trade in Guidewire Software Inc is the sale of 25,191 shares on September 18, 2012, which brought Presidio Management Group Viii L L C around $787,723.
According to the SEC Form 4 filings, Presidio Management Group Viii L L C has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 13,052 shares on June 10, 2014, which brought Presidio Management Group Viii L L C around $320,688.
More details on Presidio Management Group Viii L L C's insider transactions can be found in the Insider Trading History of Presidio Management Group Viii L L C table.Insider Trading History of Presidio Management Group Viii L L C
- 1
Presidio Management Group Viii L L C Trading Performance
GuruFocus tracks the stock performance after each of Presidio Management Group Viii L L C's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Presidio Management Group Viii L L C is -41.88%. GuruFocus also compares Presidio Management Group Viii L L C's trading performance to market benchmark return within the same time period. The performance of stocks bought by Presidio Management Group Viii L L C within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Presidio Management Group Viii L L C's insider trading performs compared to the benchmark.
Performance of Presidio Management Group Viii L L C
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.99 | | | | | |
| Relative Return to S&P 500(%) | -35.28 | | | | | |
Presidio Management Group Viii L L C Ownership Network
Ownership Network List of Presidio Management Group Viii L L C
Ownership Network Relation of Presidio Management Group Viii L L C
Presidio Management Group Viii L L C Owned Company Details
What does OncoMed Pharmaceuticals Inc do?
Who are the key executives at OncoMed Pharmaceuticals Inc?
Presidio Management Group Viii L L C is the 10 percent owner of OncoMed Pharmaceuticals Inc. Other key executives at OncoMed Pharmaceuticals Inc include See Remarks Sunil Patel , Chairman & CEO Paul J Hastings , and SVP & Chief Medical Officer Jakob Dupont .
OncoMed Pharmaceuticals Inc (OMED) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of OncoMed Pharmaceuticals Inc (OMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoMed Pharmaceuticals Inc (OMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
OncoMed Pharmaceuticals Inc (OMED)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoMed Pharmaceuticals Inc Insider Transactions
Presidio Management Group Viii L L C Mailing Address
Above is the net worth, insider trading, and ownership report for Presidio Management Group Viii L L C. You might contact Presidio Management Group Viii L L C via mailing address: 2735 Sand Hill Road, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
